HIST1H1B Promotes Basal-Like Breast Cancer Progression by Modulating CSF2 Expression

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• Basal-like breast cancer (BLBC) exhibits poor prognosis, with underlying mechanisms of aggressiveness poorly understood.
• Linker histones are known regulators of gene expression in various cancers.
• The role of HIST1H1B in BLBC progression requires elucidation.

Purpose of the Study:

• To investigate the involvement and mechanism of HIST1H1B in the progression of basal-like breast cancer.
• To determine if HIST1H1B expression correlates with BLBC aggressiveness and patient survival.

Main Methods:

• Analysis of gene expression datasets to correlate HIST1H1B levels with BLBC.
• Quantitative real-time PCR, transwell, colony formation, and mammosphere assays to study HIST1H1B's molecular role.
• Chromatin immunoprecipitation (ChIP) assay to assess HIST1H1B binding to the CSF2 promoter.
• Tumorigenesis assays to evaluate the impact of HIST1H1B on BLBC cell tumorigenicity.

Main Results:

• HIST1H1B is significantly elevated in BLBC due to copy number amplification and promoter hypomethylation.
• HIST1H1B upregulates colony-stimulating factor 2 (CSF2) expression via direct promoter binding.
• Increased HIST1H1B expression enhances, while its knockdown suppresses, tumor formation and growth.
• HIST1H1B expression correlates with larger tumor size, higher grade, metastasis, and poorer survival in breast cancer patients.

Conclusions:

• HIST1H1B drives BLBC progression by modulating CSF2 expression.
• HIST1H1B serves as a potential prognostic biomarker for BLBC.
• HIST1H1B represents a potential therapeutic target for basal-like breast cancer.